1. Home
  2. UMBF vs GH Comparison

UMBF vs GH Comparison

Compare UMBF & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UMBF
  • GH
  • Stock Information
  • Founded
  • UMBF 1913
  • GH 2011
  • Country
  • UMBF United States
  • GH United States
  • Employees
  • UMBF N/A
  • GH N/A
  • Industry
  • UMBF Major Banks
  • GH Medical Specialities
  • Sector
  • UMBF Finance
  • GH Health Care
  • Exchange
  • UMBF Nasdaq
  • GH Nasdaq
  • Market Cap
  • UMBF 5.5B
  • GH 4.3B
  • IPO Year
  • UMBF N/A
  • GH 2018
  • Fundamental
  • Price
  • UMBF $116.92
  • GH $37.46
  • Analyst Decision
  • UMBF Buy
  • GH Strong Buy
  • Analyst Count
  • UMBF 7
  • GH 14
  • Target Price
  • UMBF $123.14
  • GH $39.93
  • AVG Volume (30 Days)
  • UMBF 441.5K
  • GH 1.8M
  • Earning Date
  • UMBF 01-28-2025
  • GH 02-20-2025
  • Dividend Yield
  • UMBF 1.38%
  • GH N/A
  • EPS Growth
  • UMBF 2.85
  • GH N/A
  • EPS
  • UMBF 8.01
  • GH N/A
  • Revenue
  • UMBF $1,523,550,000.00
  • GH $692,256,000.00
  • Revenue This Year
  • UMBF N/A
  • GH $32.21
  • Revenue Next Year
  • UMBF $46.14
  • GH $16.90
  • P/E Ratio
  • UMBF $14.09
  • GH N/A
  • Revenue Growth
  • UMBF 7.93
  • GH 29.20
  • 52 Week Low
  • UMBF $76.00
  • GH $15.81
  • 52 Week High
  • UMBF $129.94
  • GH $39.29
  • Technical
  • Relative Strength Index (RSI)
  • UMBF 53.46
  • GH 66.67
  • Support Level
  • UMBF $105.99
  • GH $34.80
  • Resistance Level
  • UMBF $115.40
  • GH $37.46
  • Average True Range (ATR)
  • UMBF 3.42
  • GH 1.78
  • MACD
  • UMBF 0.16
  • GH 0.51
  • Stochastic Oscillator
  • UMBF 78.86
  • GH 80.49

About UMBF UMB Financial Corporation

UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking, asset management, and health spending solutions. Its customer base includes commercial, institutional, and personal customers across the United States. The company's banking subsidiaries own and operate banking and wealth-management centers mostly throughout the Midwest and Southwest regions of the U.S. Subsidiaries of the holding company and its lead bank, UMB Bank, include mutual fund and alternative investment services groups, single-purpose companies that deal with brokerage services and insurance, and a registered investment advisory. The bank's revenue is split nearly evenly between interest income and noninterest income.

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: